Skip to main content
Caplight Logo









ND Biosciences

ND Biosciences

Private
EpalingesHealthcare & Life Scienceshttps://nd-biosciences.com/

Last Round

Seed

Oct 11, 2022

Total Funding Raised

$110,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ND Biosciences is a biotechnology company that develops next-generation therapeutics and diagnostics for neurodegenerative diseases like Parkinson's and Alzheimer's.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug discovery platformneurodegenerative diseasesprotein aggregationdrug discovery servicescontract research organizationCRObiotech CROParkinson's diseaseAlzheimer's diseaseprotein engineeringneurotherapeuticspathological protein aggregatesTau proteinalpha-synucleintherapeutic antibody discoveryneuronal modelspreclinical modelsearly diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ND Biosciences Comparables

Compare ND Biosciences with similar companies based on industry and business-model similarity.

ND Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innoprot
72%
AC Immune SA
68%
SeNostic GmbH
64%

ND Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 11, 2022
SeedAug 3, 2020
GrantOct 2, 2019

Key People

Founding team and executive leadership

Hilal Lashuel

Founder And Chief Scientific Officer

Founding Team

ND Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 91% MoM.

  • Apr 18, 2026

    Monthly visitors increased 258% MoM.

ND Biosciences Filings

Explore SEC and related filing metadata, where available.

ND Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ND Biosciences's valuation, stock price, and market status.

Is ND Biosciences a public or private company?

ND Biosciences is a private company.

What is the current stock price of ND Biosciences?

ND Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is ND Biosciences worth (valuation)?

Valuation information for ND Biosciences is not publicly available.

Can I buy ND Biosciences stock?

ND Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ND Biosciences's last funding round?

ND Biosciences's most recent funding round was Seed on October 11, 2022.

Who are the main investors in ND Biosciences?

Key investors in ND Biosciences include Foundation for Technological Innovation, The Michael J. Fox Foundation for Parkinson's Research.

Will ND Biosciences IPO soon?

No public IPO plans have been announced for ND Biosciences.

How can I track ND Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ND Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEpalinges
Employee Range1
Year Founded2019
Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?